However, the migration and invasion of HCC cells treated with the combination of RIPK4 and colivelin were significantly reduced (Figures 5A–H), and the protein expression of MMP-2 and MMP-9 also decreased (Figures 5I,J). The gene discussed is RIPK4; the disease is hepatocellular carcinoma.